The cumulative number of COVID-19 vaccine doses administered within the country crossed the 70 crore mark on Tuesday. The last 10 crore doses got in only 13 days, the fastest thus far , the Union Health Ministry said.
Union Minister for Health and Family Welfare Mansukh Mandaviya on Twitter congratulated all the doctors and public for the “momentous achievement”.
Numbers improve
The seven-day average number of doses administered daily has been consistently improving since August-end. the typical daily doses have improved from around 50 lakh in mid-August to 83 lakh at the top of September first week.
To fully vaccinate all adults by 2021, over 1 crore vaccinations need to be done a day within the remaining days. So far, this mark has been crossed on three days — August 27 (1.07 crore), August 31 (1.35 crore) and September 6 (1.15 crore). On Tuesday, as of 7 p.m., 72,40,929 doses are administered.
The countrywide vaccination drive was unrolled on January 16, with healthcare workers (HCWs) getting inoculated within the first phase. The vaccination of frontline workers (FLWs) started from Groundhog Day . subsequent phase commenced from March 1 for people over 60 years and people aged 45 and above with specified comorbid conditions.
The country launched vaccination for all people aged quite 45 years from April 1. the govt then expanded the drive by allowing everyone above 18 to be vaccinated from May Day As on Tuesday, 56.6% of the Indian adult population has been vaccinated with a minimum of one dose of the COVID-19 vaccine. Also, 17.4% of the adult population has been vaccinated with both doses.
In eight States/Union Territories (UTs), including Uttar Pradesh , Bihar, West Bengal and Jharkhand, the share of adults with a minimum of one dose administered remains below the five hundred mark. In nine States/UTs, including Uttarakhand, Himachal Pradesh and Sikkim, the share has increased beyond the 80% mark.
In 17 States/UTs, including Tamil Nadu , Punjab, Madhya Pradesh, Odisha and Maharashtra, the share of adults with both the doses administered remains below the 20% mark. In seven States/UTs, the share has increased beyond the 30% mark